Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 466-380-9 | CAS number: 52350-17-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
LD50 > 2000 mg/kg bw, OECD 423, Poole 2005
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 Apr-11 May 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- adopted 17 December 2001
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- Commision Directive 2004/73/EC
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom, London, England
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- CD (Crl: CD® (SD) IGS BR)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate, Kent, UK
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 to 12 weeks
- Weight at study initiation: 191 - 213 g (females)
- Fasting period before study: overnight
- Housing: rats were housed in groups of three in suspended solid-floor polypropylene cages furnished with woodflakes.
- Diet: Certified Rat and Mouse Diet (Code 5LF2), BCM IPS Limited, London, UK, ad libitum
- Water: mains drinking water, ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): at least 15
- Photoperiod (hrs dark / hrs light): 12 hrs / 12 hrs
IN-LIFE DATES: From: 13 Apr 2005 To: 11 May 2005 - Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 mg/mL (starting) and 200 mg/mL (study)
- Justification for choice of vehicle: The test material did not dissolve/suspend in distilled water.
- Lot/batch no. (if required): batch number 050214
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION: same as starting material, freshly prepared, as required
CLASS METHOD: Acute Toxic Class Method
- Rationale for the selection of the starting dose: Three fasted females were treated at a starting dose level of 300 mg/kg bw. Based on the results from this dose level further groups of fasted females were treated at a dose level of 2000 mg/kg bw. - Doses:
- 300, 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 females (starting)
6 females (study) - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity ½, 1, 2 and 4 hours after dosing and subsequently once daily for fourteen days. Individual bodyweights were recorded prior to dosing and seven and fourteen days after treatment.
- Necropsy of survivors performed: Yes
- Other examinations performed: No - Preliminary study:
- 300 mg/kg bw to three fasted female rats. No clinical signs of toxicity were noted up to the end of the 14-day observation period. No mortality occurred during the study period.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study period.
- Clinical signs:
- other: No clinical signs of systemic toxicity were observed up to the end of the 14-day observation period.
- Gross pathology:
- All animals were killed Day 14 and no abnormalities were detected at necropsy.
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- The acute oral LD50 of the test substance in female Sprague-Dawley CD rats was estimated according to this OECD 423 to be greater than 2000 mg/kg bw.
- Executive summary:
This study was conducted to assess the acute toxicity of the test item, following a single oral administration to small groups of rats. The study design provides information for hazard assessment and classification and enables a chemical to be assigned to toxicity classes but severely restricts animal usage.
A group of three female fasted rats were given the test item as a single dose by oral gavage at 300 mg/kg bw. Based on the results from this dose level, a further dose level at 2000 mg/kg bw was performed using 6 rats.
The test item was dispersed in arachis oil. All animals underwent a full necropsy. No clinical, gross pathological or body weight changes were seen in the test item dosed rats.
There were no deaths at 2000 mg/kg bw, the LD50 is considered to be > 2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
OECD 423 (2005) - This study was conducted to assess the acute toxicity of the undissolved test item, following a single oral administration to small groups of rats. The study design provides information for hazard assessment and classification and enables a chemical to be assigned to toxicity classes but severely restricts animal usage.
A group of three female fasted rats were given the test item as a single dose by oral gavage at 300 mg/kg bw. Based on the results from this dose level, a further dose level at 2000 mg/kg bw was performed using 6 rats.
The test item was dispersed in arachis oil. All animals underwent a full necropsy. No clinical, gross pathological or body weight changes were seen in the test item dosed rats.
There were no deaths at 2000 mg/kg bw, the LD50 is considered to be > 2000 mg/kg bw.
The study was conducted on the particulate nanoform (i.e. not the dissolved form). Based on dissolution study results (Rosenfeldt, 2021, Section 4) this aligns with the draft ECHA guidance (Appendix R7-1 for nanoforms applicable to Chapter R7a and R7c Endpoint specific guidance, draft v3.0, 2021), whereby testing on the nanoform should be conducted if the nanoform is not highly soluble in water (>33,3 g/L) and/or does not have a half-life of water dissolution ≤ 10 min (Appendix R7-1 for nanoforms applicable to Chapter R7a and R7c Endpoint specific guidance, draft v3.0, 2021; Figure 1). This is further supported by the lack of dissolution seen in any vehicle and at pH 4 (relevant gut pH) seen during the dissolution study (Section 4, Rosenfeldt, 2021).
Justification for classification or non-classification
In accordance with the CLP regulation (Regulation (EC) No 1272/2008), no acute toxicity classification is required as the LD50 is > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)